Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2005 May;446(5):511-6.
doi: 10.1007/s00428-005-1239-x. Epub 2005 Apr 9.

Carcinosarcoma of the prostate: two cases with distinctive morphologic and immunohistochemical findings

Affiliations
Case Reports

Carcinosarcoma of the prostate: two cases with distinctive morphologic and immunohistochemical findings

Noelia Perez et al. Virchows Arch. 2005 May.

Abstract

Carcinosarcomas (CS) of the prostate are very uncommon neoplasms defined by the admixture of malignant epithelial and mesenchymal components. We describe here two new examples of CS in two patients aged 66 and 77 years, the first without previous history of prostate adenocarcinoma and the second with a 5-year history of acinar type prostate adenocarcinoma. The diagnosis of CS was made on the cystoprostatectomy specimen in the first case and transurethral resection in the second case. Both biphasic tumours exhibited papillary areas of ductal differentiation and conventional adenocarcinoma in the epithelial component, as well as malignant fibrous histiocytoma and angiosarcomatous areas in the first case and solid, poorly differentiated epithelial areas with neuroendocrine features in the second case. Immunohistochemistry revealed over-expression of c-erb B2 in the papillary epithelial component of both cases, whereas the solid undifferentiated epithelial areas in the second patient expressed c-kit, CD10 and synaptophysin, thus conforming a very undifferentiated cell population. The angiosarcomatous component of the first case expressed CD31 and CD10. The clinical course of the cases was divergent; the first patient is free of disease after radical surgery and adjuvant therapy and the other died 5 months after the diagnosis of CS, having already developed liver metastases.

PubMed Disclaimer

References

    1. J Urol. 1991 Nov;146(5):1370-3 - PubMed
    1. Prostate. 2003 Sep 1;56(4):250-5 - PubMed
    1. Am J Clin Pathol. 1989 Aug;92(2):131-9 - PubMed
    1. J Urol. 1979 Nov;122(5):709-11 - PubMed
    1. Urol Int. 1992;48(1):105-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources